BioMADE at the 5th Annual 2025 AFCC Global Biobased Economy Conference & Exhibit
BioMADE is excited to take part in the 5th Annual 2025 AFCC Global Biobased Economy Conference & Exhibit, November 16-18, 2025, in Washington, DC! Don’t miss Steve Evans, Senior Technical Fellow at BioMADE, as he moderates the panel discussion Best Practices for Gaining Regulatory Approval for New Products. See below for session information and get all the details here.
Optimizing Collaboration in Industrial Biotech: Insights from Strategic Avalanche’s 2025 Survey | November 17, 2025 | 3:30PM - 5:00PM
The discussion will span straightforward supply contracts to intricate joint ventures and development partnerships. By dissecting the factors that drive or derail collaboration, our panel aims to equip attendees with practical tools to initiate, nurture, and manage partnerships for optimal outcomes. As the biobased industry faces increasing pressure to deliver sustainable solutions, understanding how to build and sustain effective collaborations is more critical than ever. This session will offer fresh evidence, candid perspectives, and proven practices to help stakeholders across the value chain accelerate commercialization and maximize shared value.
Moderated by James Iademarco, Strategic Avalanche LLC and featuring panelists:
Jill Zullo, BioMADE
James Iademarco, Strategic Avalanche LLC
Ken Barrett, Arzeda Corporation
Damien Perriman, EXoZymes
Best Practices for Gaining Regulatory Approval for New Products | November 17, 2025 | 3:30PM - 5:00PM
This session will offer valuable guidance for companies seeking regulatory approval for food, chemicals, and cosmetic products. Panelists will share real-world insights across multiple use categories listed below. Learn about their process, pitfalls to avoid, and other insights. Attendees will leave with a better understanding of the path they need to take to gain needed approvals.
Origin Materials will discuss navigating EPA approval for building block chemicals.
Curie Co will explain the differences between FDA and EPA jurisdiction for cosmetics, food, and household products.
LanzaTech will share lessons from bringing LanzaTech™ Nutritional Protein to market.
Food Edge Solutions will provide tips on working with U.S. regulatory agencies to support commercialization.
Geltor will highlight their PrimaColl® nutritional collagen and their successful FDA "no questions" letter process.
Moderated by Steve Evans, BioMADE Senior Technical Fellow and featuring panelists:
Erika Milczek, Curie Co.
Jennifer van de Ligt, Food Edge Solutions
Alex Ward, Origin Materials
Nick Ouzounov, Geltor
Chad Haynes, LanzaTech